United States
Oregon Health and Science University - Department of Molecular and Medical Genetics
Single-cell, triple-negative breast cancer, drug response, chromatin accessibility, cell-cell heterogeneity, cell state dynamics
AML, FLT3, Tumor Microenvironment, Gilteritinib, Aurora Kinase B, NRAS, Drug Resistance, Tyrosine Kinase Inhibitor, CPTAC
Proteomics, causal pathway analysis, cancer